HSP90-incorporating chaperome networks as biosensor for disease-related pathways in patient-specific midbrain dopamine neurons

Journal: Nature Communications

Published: 2018-10-19

DOI: 10.1038/s41467-018-06486-6

Affiliations: 18

Authors: 29

Go to article
Institutions FC
Chemical Biology Program, MSKCC, United States of America (USA) 0.31
Center for Stem Cell Biology (CSCB), MSKCC, United States of America (USA) 0.10
Developmental Biology Program, MSKCC, United States of America (USA) 0.10
Proteomics and Microchemistry Core Facility, MSKCC, United States of America (USA) 0.10
Doerenkamp-Zbinden Chair of in-vitro Toxicology and Biomedicine/Alternatives to Animal Experimentation (Leist Laboratory), University of Konstanz, Germany 0.07
Department of Pharmacology, Cornell University, United States of America (USA) 0.07
Helen L. and Martin S. Kimmel Center for Biology and Medicine at the Skirball Institute of Biomolecular Medicine, United States of America (USA) 0.03
Department of Epidemiology and Biostatistics, MSKCC, United States of America (USA) 0.03
Institute of Neurogenetics, University of Lübeck, Germany 0.03
NYU Department of Cell Biology, United States of America (USA) 0.03
Eugenio María De Hostos Community College of The City University of New York (CUNY HCC), United States of America (USA) 0.02
Department of Molecular and Cellular Biosciences, Rowan University, United States of America (USA) 0.02
Department of Chemistry and Biochemistry, ND, United States of America (USA) 0.02
Department of Medicine, MSKCC, United States of America (USA) 0.01
Memorial Hospital, MSKCC, United States of America (USA) 0.01
Sloan Kettering Institute (SKI), MSKCC, United States of America (USA) 0.01
Weill Cornell Graduate School of Medical Sciences (WCGS, Cornell-MSKCC), United States of America (USA) 0.01
SKI Stem Cell Research Facility, MSKCC, United States of America (USA) 0.01

Return